Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Myelodysplastic Syndromes/drug therapy/mortality"'
Autor:
Potter, Victoria T, Iacobelli, Simona, van Biezen, Anja, Maertens, Johann, Bourhis, Jean-Henri, Passweg, Jakob R, Yakhoub-Agha, Ibrahim, Tabrizi, Reza, Bay, Jacques-Olivier, Chevallier, Patrice, Chalandon, Yves, Huynh, Anne, Cahn, Jean Yves, Ljungman, Per, Craddock, Charles, Lenhoff, Stig, Russell, N H, Fegueux, Nathalie, Socié, Gerard, Bruno, Benedetto, Meijer, Ellen, Mufti, G J, de Witte, Theo, Robin, Marie-Claude, Kröger, Nicolaus
Publikováno v:
Biology of Blood and Marrow Transplantation, Vol. 22, No 9 (2016) pp. 1615-1620
The European Society for Blood and Marrow Transplant Research data set was used to retrospectively analyze the outcomes of hypomethylating therapy (HMA) compared with those of conventional chemotherapy (CC) before hematopoietic stem cell transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::12e5fbe6713c8b48a50e9d851a2d70b0
https://archive-ouverte.unige.ch/unige:127668
https://archive-ouverte.unige.ch/unige:127668
Publikováno v:
European journal of haematology. 55(4)
Thirty-four patients with myelodysplastic syndromes, 23 men and 11 women, aged between 47 and 80 years, with all types of myelodysplastic syndromes were treated with 13-cis-retinoic acid. The dose of retinoic acid ranged between 10 and 60 mg/m2/daily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fda16f907656216f2fe5ccf92026228
https://pubmed.ncbi.nlm.nih.gov/7589340
https://pubmed.ncbi.nlm.nih.gov/7589340
